Brendan Hannah - Net Worth and Insider Trading
Brendan Hannah Net Worth
The estimated net worth of Brendan Hannah is at least $519,123 dollars as of 2024-12-27. Brendan Hannah is the CHIEF BUSINESS OFFICER AND COO of Quince Therapeutics Inc and owns about 296,540 shares of Quince Therapeutics Inc (QNCX) stock worth over $519,123. Details can be seen in Brendan Hannah's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brendan Hannah has not made any transactions after 2024-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brendan Hannah
Brendan Hannah Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brendan Hannah owns 1 companies in total, including Quince Therapeutics Inc (QNCX) .
Click here to see the complete history of Brendan Hannah’s form 4 insider trades.
Insider Ownership Summary of Brendan Hannah
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2024-08-21 | Chief Business Officer |
Brendan Hannah Latest Holdings Summary
Brendan Hannah currently owns a total of 1 stock. Brendan Hannah owns 296,540 shares of Quince Therapeutics Inc (QNCX) as of August 21, 2024, with a value of $519,123.
Latest Holdings of Brendan Hannah
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2024-08-21 | 296,540 | 1.75 | 519,123 |
Holding Weightings of Brendan Hannah
Brendan Hannah Form 4 Trading Tracker
According to the SEC Form 4 filings, Brendan Hannah has made a total of 2 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Quince Therapeutics Inc is the acquisition of 38,924 shares on August 21, 2024, which cost Brendan Hannah around $24,133.
Insider Trading History of Brendan Hannah
- 1
Brendan Hannah Trading Performance
GuruFocus tracks the stock performance after each of Brendan Hannah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brendan Hannah is 101.44%. GuruFocus also compares Brendan Hannah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brendan Hannah within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brendan Hannah's insider trading performs compared to the benchmark.
Performance of Brendan Hannah
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.65 | | | | | |
| Relative Return to S&P 500(%) | 19.39 | | | | | |
Brendan Hannah Ownership Network
Brendan Hannah Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Brendan Hannah is the Chief Business Officer of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include director & Chief Executive Officer Dirk Thye , President Charles S. Ryan , and Chief Scientific Officer Guenter Janhofer .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Brendan Hannah made 2 insider transaction in Quince Therapeutics Inc (QNCX) with a net purchase of 110,686. Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 48,387 shares made by Charles S. Ryan .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Brendan Hannah Mailing Address
Above is the net worth, insider trading, and ownership report for Brendan Hannah. You might contact Brendan Hannah via mailing address: 269 East Grand Ave, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
